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ABSTRACT: The gut microbiota guide the development of the host immune
system by setting a systemic threshold for immune activation. Lipopolysacchar-
ides (LPSs) from gut bacteria are able to trigger systemic and local
proinflammatory and immunomodulatory responses, and this capability strongly
relies on their fine structures. Up to now, only a few LPS structures from gut
commensals have been elucidated; therefore, the molecular motifs that may be
important for LPS−mammalian cell interactions at the gut level are still obscure.
Here, we report on the full structure of the LPS isolated from one of the
prominent species of the genus Bacteroides, Bacteroides vulgatus. The LPS turned
out to consist of a particular chemical structure based on hypoacylated and
mono-phosphorylated lipid A and with a galactofuranose-containing core
oligosaccharide and an O-antigen built up of mannose and rhamnose. The
evaluation of the immunological properties of this LPS on human in vitro
models revealed a very interesting capability to produce anti-inflammatory
cytokines and to induce a synergistic action of MD-2/TLR4- and TLR2-mediated signaling pathways.
■ INTRODUCTION
The gastrointestinal tract is in incessant contact with
microorganisms, collectively defined as “microbiota”, which
have profound impacts on the host immune system. The
crosstalk between microbiota and the immune system at the
level of the gut mucosa is crucial as it not only enables the
tolerance of commensal microbes but also allows the immune
system to recognize and fight pathogens thus preventing
microbial invasion and infection.1,2 The nature of the microbial
signals and the cellular mechanisms underlying such host−
microbe interactions are still enigmatic and need further
studies.
Innate immune recognition of microbes relies on the
detection of conserved microbial structures, known as
“microbe-associated molecular patterns” (MAMPs) such as
lipopolysaccharides (LPSs), whose detection by the host
immune system is at the basis of infection, inflammation, or
symbiosis via an intracellular signaling.3,4 LPSs, the main
constituents of the Gram-negative outer membrane, have a
general structural architecture built up of three structural
domains: a glycolipid portion termed lipid A, and a
heteropolysaccharide composed of the core oligosaccharide
(core OS) and the O-polysaccharide moiety (or O-chain).5,6 In
mammals, the lipid A portion is recognized by the innate
immunity receptor complex built up of myeloid differentiation
protein-2 (MD-2) and Toll-like receptor 4 (TLR4).7 It is
widely attested that the immunopotential of an LPS is
correlated to its fine structure; namely, defined LPS molecules
act as agonists of the MD-2/TLR4 complex, triggering the
immune response culminating in production of proinflamma-
tory cytokines. Nevertheless, some other LPSs act as antagonist
agents by preventing the binding of toxic LPS to the receptor
complex, therefore inhibiting or limiting the dangerous effects
on infected cells.8
In this context, a still pending key question is how the
molecular interactions between LPS and its receptors, and the
subsequent signaling pathways, lead to disease vs commens-
alism or even mutualism. Since it is widely accepted that the
innate immune responses, upon stimulation by LPS, are finely
tuned by its chemical composition,3−8 one can envision that
commensal gut microbiota express “modified” LPS structures
well tolerated/not rejected by the host immune system.9
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Therefore, a crucial point to be addressed is what commensal
gut microbiota LPS looks like. To shed light on this, we have
started a program aimed at looking for the structure to
function relationship of LPS from gut microbiota. First we
focused our attention on Bacteroides, the prominent Bacter-
oidetes representative in the gastrointestinal tract of the
healthy American and Western European population, whose
members can be considered as commensal, mutualist, or even
pathobiont microorganisms.10 Bacteroides surface structures
have been shown to exert immunomodulatory effects.
Examples are given by the capsular polysaccharide component
from Bacteroides f ragilis11,12 but also the LPS from Bacteroides
dorei that in a study by Vatanen et al. was shown to promote
immunological tolerance.13 Recently, we demonstrated that
Bacteroides vulgatus strain mpk, commensal of murine intestine,
exerts strong immune-modulating properties leading to
prevention of colitis-induction in several mouse models for
experimental colitis.14−16 Furthermore, we showed that its
isolated LPS (LPSBv) does not induce expression of
proinflammatory cytokines but actively induces hyporespon-
siveness toward subsequent LPS-stimuli in CD11c+ cells in
murine in vitro systems,17 thereby fairly merging properties of
TLR4 antagonists and agonists. Therefore, we proposed LPSBv
acting as a “weak agonist” concerning its interaction with the
murine MD-2/TLR4 receptor complex.17 Importantly, in the
same work we also proved that the administration of purified
LPSBv reestablishes intestinal immune homeostasis in a mouse
model for experimental colitis and correlated these health-
promoting effects to the weak agonistic properties of this LPS
exploited through induction of a special type of LPS tolerance
in intestinal lamina propria CD11c+ cells, via the MD-2/TLR4
receptor complex axis.17 Given that the administration of the
sole LPSBv in mice caused the restoring of the homeostasis in
intestine after severe inflammation, this phenomenon must of
course be attributed to its chemical structure, and therefore, we
have decided to establish the full structure of its LPS.
Here, we report on the full characterization of the LPSBv
chemical structure achieved by the combined use of chemical,
spectroscopic, and spectrometric techniques. Puzzled by the
immunological properties of LPSBv observed in murine
systems, we wondered whether the observed activity could
be mirrored in human in vitro systems. Therefore, we also
evaluated the impact of LPSBv on the human innate immune
system by using HEK cell lines, human macrophages, and
dendritic cells and discovered that to an intriguing chemical
structure corresponded an equally intriguing immunological
behavior.
■ STRUCTURAL CHARACTERIZATION OF B.
VULGATUS LPS: PURIFICATION AND CHEMICAL
ANALYSES
In order to define the full structure of the LPSBv, a
multidisciplinary approach was employed. In detail, a set of
chemical analyses, on both intact and isolated LPS domains,
was executed, furnishing the chemical composition of each LPS
moiety.
LPS material was extracted from lyophilized bacterial cells
by the hot phenol/water procedure.18 The extracted LPS
underwent an enzymatic digestion by DNase, RNase, and
proteases in order to remove cell contaminants. A further step
of purification by size-exclusion chromatography and ultra-
centrifugation was also performed. The nature and purity of
the LPSBv was determined by SDS-PAGE analysis after silver
nitrate gel staining,19 disclosing the smooth nature of the
extracted LPS, as proven by the ladderlike pattern in the upper
part of the gel indicating the occurrence of high-molecular-
weight species, i.e., the O-chain moiety (Figure S1a). In
parallel, no bands were visible in an additional SDS-PAGE
analysis followed by Coomassie Brilliant Blue gel staining
(Figure S1b) which was indicative of the absence of any
contaminating protein/lipoprotein in the isolated LPS materi-
al. Furthermore, the Micro BCA protein assay has been also
executed disclosing a protein content of less than 1% (i.e., ≤0.8
μg/mL) in the presence of 2% SDS as requested by
manufacturer protocol to remove most of the well-known
lipid interferences (Figure S1c).20,21 However, it should be
noted that the obtained value (≤0.8 μg/mL) (Figure S1c) was
close to the lower limit of detection of the Micro BCA protein
assay. For this reason (being close to the lower limit of
detection) and due to the presence of lipids (i.e., the lipid A
moiety), there are significant overestimations of the actual
protein content (if any). In addition, as reported, the 2% SDS
treatment remove only 70−80% of the lipid interferences.20,21
Chemical analyses22−24 executed on pure LPS revealed the
presence of terminal, 4-substituted and 3,4-disubstituted L-
rhamnopyranose (L-Rhap), terminal L-fucopyranose (L-Fucp),
terminal galactofuranose (D-Galf), 3-substituted D-mannopyr-
anose (D-Manp), 3-substituted D-glucopyranose (D-Glcp), 2,6-
disubstituted D-galactopyranose (D-Galp), 6-substituted amino-
D-glucopyranose (D-GlcpN), and 5-substituted Kdo. Fatty acid
analysis25 showed the occurrence of tetradecanoic acid
(C14:0), pentadecanoic acid (C15:0), hydroxypentadecanoid
acid (C15:0(3-OH)), hydroxyhexadecanoid acid (C16:0(3-
OH)), and hydroxyheptadecanoic acid (C17:0(3-OH)), in full
agreement with previously reported data by Hashimoto et al.
on the structure of lipid A from B. vulgatus IMCJ 1204.26
■ STRUCTURAL CHARACTERIZATION OF B.
VULGATUS LPS: NMR OF THE SACCHARIDE
PORTION
An aliquot of the pure LPS isolated from B. vulgatus mpk
underwent a full deacylation27 furnishing the complete LPS
saccharide portion. The deacylated LPS fraction was then
purified by gel permeation chromatography. Monosaccharide
analysis of the isolated product confirmed the presence of the
sugar residues detected in the intact LPS. The deacylated
product was then analyzed by 1D and 2D NMR spectroscopy.
A combination of homo- and heteronuclear 2D NMR
experiments (DQF-COSY; TOCSY; NOESY; ROESY; 1H,
13C HSQC; 1H, 13C HMBC; and 31P and 1H, 31P HSQC) was
performed in order to elucidate the complete saccharide
sequence of LPSBv. In detail, each spin system was assigned on
the basis of the spin connectivity observed in both the double-
quantum-filtered correlation spectroscopy (DQF-COSY) and
the total correlation spectroscopy (TOCSY) spectra; each
carbon atom was identified through the analysis of the
heteronuclear single-quantum coherence (HSQC) spectrum.
The anomeric configuration of all sugar units was defined by
intra-residual NOE contacts, detectable in the nuclear
Overhauser effect spectroscopy (NOESY) spectrum and the
3JH‑1,H‑2 coupling constants from the DQF-COSY spectrum.
The assignment of the relative configuration of each sugar
residue was obtained through the observation of the vicinal
3JH,H coupling constant values. The combined study of
rotating-frame NOE spectroscopy (ROESY), NOESY, and
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HMBC (heteronuclear multiple-bond correlation spectrosco-
py) spectra allowed the characterization of the entire primary
structure of the LPS saccharide part. Finally, 31P and 31P, 1H
HSQC experiments were pivotal to establish the location of
the phosphate group decorating the LPSBv.
In the 1H NMR spectrum (Figure 1) 11 anomeric signals
from 11 spin systems were clearly identified (A−L; Table 1);
furthermore, the signals at δH 1.77 and 2.02 ppm were
attributed to the H-3 methylene protons of the Kdo unit (K;
Table 1). All the monosaccharide residues, except for D, were
present as pyranose rings, according to both 13C chemical shift
values and the presence of long-range correlations between C-
1/H-1 and H-5/C-5 observable in the 1H, 13C HMBC
spectrum (for the Kdo residue between C-2 and H-6).28
Conversely, residue D was present as a furanose ring as shown
by the occurrence of low-field shifted ring carbon signals
resonating around δC 82.0 ppm and anomeric carbon over δC
108 ppm and further confirmed by the intra-residual long-
range H/C 1−4 correlations in the 1H, 13C HMBC spectrum.
Spin systems A (H-1 δ 5.50 ppm) and B (H-1 δ 4.90 ppm)
were identified as the α-GlcpN and β-GlcpN of the lipid A
moiety based on their H-2 proton signals, which correlated
with two nitrogen-bearing carbon atoms at δC 54.3 and δC 55.6
ppm, respectively (Table 1, Figure S2). This hypothesis was
also corroborated by the presence of an inter-residue contact
between H-1 of B and H-6a,b of A observed in the NOESY
spectrum (not shown). Furthermore, the occurrence of a
correlation in the 31P, 1H HSQC spectrum (not shown),
between the signal at δ 2.99 ppm and the anomeric proton
signal of residue A (δH 5.50 ppm, Table 1, Figure S2), allowed
the allocation of a phosphate group at such a position. Spin
systems C, G, G′, and I were identified as α-rhamnopyranose
residues as proven by the correlations, in the TOCSY
spectrum, with the methyl group signals resonating at δH
1.23 and 1.24 ppm (δC 16.9 and 17.0 ppm; Table 1),
respectively. As mentioned above, the α-anomeric config-
uration was determined on the basis of the 3JH‑1,H‑2 coupling
constant values and the intra-residual NOE contact of H-1
Figure 1. 1H NMR of fully deacylated LPSBv. A zoom of the anomeric
region is reported in the inset. Anomeric signals in the inset are as
attributed in Table 1.
Table 1. 1H, 13C (italic) and 31P (bold) Chemical Shift Values of the Saccharide Region of the LPSBv
chemical shifts (δ)
unit 1 2 3 4 5 6 7 8
A, 6-α-GlcpN 5.5 3.22 3.81 3.27 4.07 4.12/3.80
90.4 54.3 69.9 70.1 73 68
2.99
B, 6-β-GlcpN 4.9 2.86 3.52 3.43 3.55 3.69/3.47
99.6 55.6 72.3 69.8 74.5 61.3
C, 3,4-α-Rhap (α-RhaI) 5.11 4.16 3.96 3.85 3.85 1.23
101 70.2 78.9 73.6 68.6 16.9
D, t-β-Galf 5.07 4.06 3.96 3.92 3.72 3.56
108.6 81.8 77 82.8 70.3 62.7
E, t-α-Fucp 5.09 3.67 3.76 3.71 4.27 1.14
99.4 68.3 71.4 73.2 66.9 16.2
F, 3-β-Glcp 4.47 3.29 3.48 3.36 3.36 3.82/3.62
102.5 73.5 82.4 69.9 75.6 60.8
G, t-α-Rhap (α-RhaII) 5.01 3.93 3.81 3.34 3.96 1.22
100.8 70.4 69.7 71.9 67.4 17
G′, 4-α-Rhap (α-Rha′II) 5 3.93 ND 3.58 3.88 1.22
100.8 70.4 ND 79.4 67.5 17
H, 2,6-β-Galp 4.72 3.45 3.75 3.8 3.71 3.93
100.2 76.8 71.4 69.7 70.6 69
I, 4-α-Rhap (α-RhaOC) 4.86 3.9 3.94 3.58 3.89 1.22
99.7 70.3 70.3 79.4 67.5 17
L, 3-β-Manp 4.78 4.17 3.58 3.54 3.29 3.82/3.64
100.3 66.6 76.6 65 76.1 60.8
K, 5-α-Kdop 1.77/2.02 4.15 4.07 3.68 3.96 3.95/3.86
34.5 67.2 73.3 70.5 70.2 65.6
1.64
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with H-2, whereas the manno configuration was established by
evaluation of 3JH,H coupling constant values.
Spin systems D, E, and H were attributed to galacto-
configured sugar units. In detail, residue D (H-1 δ 5.07 ppm,
Table 1), as stated above, was revealed to be a β-
galactofuranose (anomeric carbon signal at δ 108.6 ppm,
Table 1) based on its chemical shifts and intra-residual scalar
and dipolar correlations. By contrast, spin system H (H-1 δ
4.72 ppm) was assigned to a β-galactopyranose, as proven by
the chemical shift values of ring protons and the 3JH,H ring
coupling constants; furthermore, the large 3JH‑1,H‑2 values and
the NOE correlations of H-1 with H-3 and H-5 were indicative
of the β-anomeric configuration. The galacto-configured sugar
residue E (H-1 δ 5.09 ppm) was identified as an α-
fucopyranose as shown by the correlations, in the TOCSY
spectrum, with the methyl proton signal at δH 1.14 ppm (δC
16.2 ppm) and the 3JH‑1,H‑2 coupling constant values that
confirmed the α-anomeric configuration.
Spin system F (H-1 δ 4.47 ppm) was assigned to a β-
glucopyranose as indicated by the large 3JH,H ring coupling
constants and the chemical shift values of ring protons, in
agreement with the gluco-configuration of pyranose rings
(Table 1). Moreover, the large 3JH‑1,H‑2 values, together with
the NOE contacts of H-1 with H-3 and H-5, were diagnostic of
the β-anomeric configuration. Finally, spin system L (H-1 δ
4.78 ppm) was attributed to a β-mannopyranose residue, as
proven by the small 3JH‑1,H‑2 and
3JH‑2,H‑3 values, diagnostic of a
H-2 equatorial orientation, whereas the intra-residual correla-
tions between H-1 and H-5 in the NOESY and ROESY spectra
allowed the β configuration assignment. The assignment of the
Kdo unit (K) was achieved starting from the diastereotopic
methylene signal, and its anomeric α-configuration was
assigned on the basis of the chemical shift values of H-3 (δ
1.77/2.02 ppm, Table 1), and of the 3JH‑7,H8a and
3JH‑7,H‑8b
coupling constants.28,29 Moreover, the Kdo residue was
phosphorylated at position O-4, due to the occurrence of a
correlation with a signal at 1.64 ppm in the 31P, 1H HSQC
spectrum (not shown).
The downfield shifted carbon signals were indicative of
glycosylation at position O-6 of A and B, O-5 of K, O-3 and O-
4 of C, O-2 and O-6 of H, O-3 of F and L, and O-4 of I and
G′, whereas D, E, and G were terminal sugar residues, in full
accordance with the methylation data. The analysis of the inter-
residual NOE contacts (observable in both the NOESY and
ROESY spectra) and the long-range correlations in the HMBC
spectrum (Figure 2) allowed the defining of the complete
sugar sequence of the LPS from B. vulgatus mpk. Starting from
the lipid A disaccharide backbone, made up of residue A and B,
this latter sugar unit was found to be substituted at position O-
6 by the Kdo residue (K); this was further confirmed by the
weak downfield shift of signal of C-6 of residue B (δ 61.3 ppm,
Table 1), which is consistent with the α-(2→6) ketosidic
linkage of Kdo with the β-GlcN of the lipid A. The Kdo unit
was, in turn, substituted at position O-5 by the rhamnose
residue C, as suggested by the long-range correlation between
the anomeric proton signal of residue C and the carbon atom
at δ 73.3 ppm (C-5, Table 1) of residue K (Figure 2).
Rhamnose C was revealed to be substituted at both positions
O-3 and O-4 by the galacto-configured sugar units D and H,
respectively, as showed by the occurrence of the strong NOE
contacts between H-1 of D and H-3 of C and between H-1 of
H and H-4 of C. These glycosydic linkages were also
confirmed by the observation of the respective long-range
correlations in the HMBC spectrum (Figure 2). Residue H, in
turn, was substituted by the α-Fuc E at position O-2 and by the
β-Glc F at position O-6, as proven by the long-range
correlations between the H-1 of E and the C-2 signal of H,
and H-1 of F and C-6 of H (Figure 2). This latter residue F
turned out to be substituted at position O-3 by rhamnose G, as
suggested by the long-range contact between the anomeric
proton signal of G and the carbon atom signal at δ 82.4 ppm
(C-3, Table 1) of β-glucose F. Interestingly, 2D NMR analysis
allowed the identification of a second slight different glycoform
of rhamnose G, referred to here as G′, differing for the
presence of a glycosylated position, namely, position O-4
(Table 1). Sugar units I and L were attributed to the
Figure 2. Zoom of the overlapped 1H, 1H, 13C HMBC (blue) and 1H, 13C HSQC (black and red) NMR spectra. The key inter-residual long-range
correlations involving sugar moieties (A−L) are indicated; letters are as in Table 1. Anomeric one-bond heteronuclear correlations were also
reported in the spectrum.
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components of the disaccharide repeating unit of the O-chain
moiety as demonstrated by the long-range correlation of the
anomeric proton signal of β-Man L with the carbon atom
signal C-4 of α-RhaOC I (Figure 2); further on, an HMBC
correlation between the anomeric proton signal of I and C-3 of
β-Man L was also clearly visible. These data were in full
agreement with the LPS O-chain repeating unit previously
elucidated by Hashimoto et al.26 Finally, we were also able to
establish the biological repeating unit; in fact, residue G′,
assigned to a 4-substituted α-Rha, was identified as the sugar
likely connecting the O-chain moiety to the core region, as
proven by the long-range correlation between H-1 of L and C-
4 of G′ (Figure 2). This hypothesis was also confirmed by
mass spectrometry (MS) and MS2 data (see below).
All the above information taken together allowed the
establishing of the complete structure of the fully deacylated
LPSBv as sketched below:
■ STRUCTURAL CHARACTERIZATION OF B.
VULGATUS LPS: MASS SPECTROMETRY ANALYSIS
The fully deacylated LPSBv was also analyzed by electrospray
ionization (ESI) mass spectrometry (MS). The corresponding
spectrum is reported in Figure S3a. The detailed investigation
of the double and triple charged ions in the spectrum in the
mass range m/z 400−1130 allowed the determination of the
fine structure of the LPS saccharide domain. In detail, the
spectrum showed three main signal clusters (M1−M3) of
double charged ions (m/z 821.3, 975.4, and 1129.4, Figure S3a
and Table S1) originating from the monoisotopic molecules
with a mass of 1644.47, 1952.58, and 2260.69 (calculated
molecular masses 1644.6, 1952.8, and 2260.8 Da), respectively,
differing by 308 u, which corresponded to the mass of an O-
chain repeating unit (RU) built up of a hexose and a
deoxyhexose, thus in full agreement with the NMR data.
Briefly, M1 (the most abundant species) and M2 contained
one and two O-chain RU, respectively, whereas M3 possessed
three O-chain RU. Interestingly, the main peak m/z 667.3 was
attributed to the double charged ion originating from the
monoisotopic mass of 1336.36 (calculated molecular mass
1336.6 Da) which is consistent with an oligosaccharide
composed of two hexosamines, one Kdo, two hexoses, two
deoxyhexoses, and two phosphates. The structural sequence of
the core OS was also corroborated by the ESI-MS2
investigation executed on precursor ion 1336.36 which is
reported in Figure S3b. The spectrum showed the occurrence
of a daughter ion at m/z 419.2 (Y2) originating from the
monoisotopic mass 420.11 (calculated molecular mass 420.2
Da) assignable to the mono-phosphorylated diglucosamine
backbone of the lipid A. Moreover, the daughter ion at m/z
915.4 (B3) relative to a mass of 916.24 (calculated mass 916.4
Da) was attributed to the oligosaccharide fragment made up of
one Kdo, one phosphate, two hexoses, and two deoxy-hexoses.
Finally, the ESI-MS spectrum revealed also the occurrence of
the two double charged ions at m/z 627.3 and 748.3 relative to
the monoisotopic masses 1256.39 and 1498.41 (calculated
molecular masses 1256.6 and 1498.6 Da), respectively, which
matched with the above-described core OS minus a phosphate
group (1256.39) or carrying a further hexose unit (1498.41).
Therefore, all above-mentioned MS and MS2 data were in full
accordance with the NMR structural elucidation of the
saccharide moiety of the LPSBv.
In order to define also the structure of the glycolipid portion
of the LPSBv, an aliquot of pure LPS underwent a mild acid
hydrolysis in order to selectively cleave the acid-labile linkage
between the Kdo and the β-GlcN unit and to isolate the lipid A
fraction. After purification, this latter was then analyzed by
MALDI MS. The MALDI MS spectrum (Figure S4), acquired
in negative polarity, matched perfectly with the MS analysis
executed by Hashimoto et al.26 In detail, a high heterogeneity
of lipid A species was immediately apparent as demonstrated
by the occurrence of two clusters of signals differing in the
number of the fatty acid chains (Figure S4). Moreover, each of
these groups of ions was characterized by the presence of mass
differences that can be explained with the presence of lipid A
species differing in the fatty acid chain length. In detail, the
most intense cluster of ions in the mass range m/z 1617−1717
Da (Figure S4) was consistent with mono-phosphorylated
penta-acylated lipid A species whose fatty acid distribution and
composition, for instance for the ion peak at m/z 1688.28, was
determined as two C17:0(3-OH) as N-linked acyl chains, two
C16:0(3-OH) as primary O-linked fatty acids, and C15:0 as a
secondary O-acyl substitution. The less intense cluster of ions
visible in the mass range m/z 1385−1479 Da (Figure S4) was
attributed to mono-phosphorylated tetra-acylated lipid A
species with the main ion peak at m/z 1436.02 assigned to a
lipid A possessing the above-mentioned fatty acid distribution
and composition but lacking one primary O-linked C16:0(3-
OH).
Therefore, the overall data led to the delineation of the full
structure of LPSBv as sketched in Figure 3. Moreover, a first
indication of the 3D perspective of the dynamic behavior in
water of both the tetra- and penta-acylated forms of LPSBv is
reported in Figures S5−S7.




BY B. VULGATUS LPS AND LIPID A
Once the structure was defined at a molecular level, we then
passed to the immunological evaluation of LPSBv and its
isolated lipid A portion (Lipid ABv) on human peripheral
blood-monocyte-derived macrophages (MoMs) and on
peripheral blood-monocyte-derived dendritic cells (MoDCs).
LPSBv and lipid ABv were used to stimulate MoMs and MoDCs
at the concentration of 1, 10, and 100 ng/mL. The agonistic
hexa-acylated Escherichia coli O111:B4 LPS and the synthetic
antagonist tetra-acylated lipid IVA at the same concentration as
above were used as controls. Untreated cells were considered
the negative control in all the experiments. The release of
cytokines tumor necrosis factor-α (TNF-α) (Figure 4a,e),
interleukin-6 (IL-6) (Figure 4b,f), the chemokine IFN-γ-
inducible protein-10 (IP-10) (Figure 4c,g), and the inter-
leukin-10 (IL-10) (Figure 4d,h) were quantified by ELISA
after 12 h of stimulation. The choice has fallen on these
cytokines/chemokines as they are the most representative to
demonstrate the inflammatory (TNF-α and IL-6) and anti-
inflammatory (IL-10) response following an LPS stimuli.
Importantly, it is known that, following the recognition of LPS
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by TLR4, two signaling pathways mediated by the adaptor
molecules MyD88 and TRIF, respectively, are triggered. Both
pathways lead to the activation of the nuclear factor-κB (NF-
κB) and the production of the proinflammatory mediators,
while the only TRIF pathway promotes the production of type
I interferon and the interferon-related cytokines/chemokines,
such as the chemokine IP-10.30 Therefore, the measurement of
this chemokine was chosen to assess whether LPSBv can
activate the TRIF pathway in addition to the MyD88 pathway.
In MoMs the amount of TNF-α triggered by LPSBv
stimulation at 100 ng/mL was significantly reduced with
respect to that of E. coli LPS at the same concentration (p <
0.5) but comparable to that of E. coli LPS at 10 ng/mL (Figure
4a). Likewise, a similar trend was observed for the cytokine IL-
6 (Figure 4b) as at the concentration of 100 ng/mL no
significant difference was detected with E. coli LPS. The
chemokine IP-10 yield triggered by 100 ng/mL of LPSBv was
appreciable (Figure 4c) but significantly lower (p < 0.001)
than that of E. coli LPS at the same and minor concentration
(10 ng/mL). Finally, upon stimulation with 100 ng/mL LPSBv
or E. coli LPS, IL-10 production (Figure 4d) was comparable
while at 10 ng/mL the difference between these values was
highly significant (p < 0.01). Lipid ABv did not produce the
release of the cytokines measured with the exception of IL-6
that was scantly but significantly produced (p < 0.001, for
Lipid ABv vs untreated cells) at the concentration of 100 ng/
mL (Figure 4b). As expected, no cytokine production was
observed with lipid IVA.
In MoDCs, LPSBv triggered the production of TNF-α
(Figure 4e) which was significantly lower than that of E. coli (p
< 0.001 for all concentrations LPSBv vs E. coli LPS). IL-6
(Figure 4f) was produced in small amount at 1 and 10 ng/mL
(p < 0.001 for LPSBv at 1 and 10 ng/mL vs E. coli LPS at the
same concentrations) while at 100 ng/mL the two yields were
comparable. No release of TNF-α and IL-6 was seen following
lipid ABv stimulation at all the concentrations tested (Figure
4e,f). The chemokine IP-10 (Figure 4g) was poorly detectable
upon stimulation with either LPSBv or lipid ABv. In line with the
trend observed in MoMs, in MoDCs IL-10 (Figure 4h) release
by LPSBv was lower than that elicited by E. coli LPS at 1 and 10
ng/mL (p < 0.01 and p < 0.05, respectively, for LPSBv vs E.coli
LPS at the same concentrations) while at 100 ng/mL no
statistical difference between the two values was found.
Likewise, lipid ABv elicited an exiguous but still detectable
production of IL-10 (p < 0.01 for lipid ABv vs untreated cells).
Furthermore, we also measured via ELISA the release of IL-
6, IL-10 (Figure S8), and IFN-α by MoDCs after stimulation
with LPSBv and E. coli LPS at different time points. This
analysis confirmed the lower capacity of LPSBv in eliciting the
production of IL-6 and IL-10 compared to E. coli LPS; finally,
the absence of any detection of IFN-α, in addition to the poor
detectability of the chemokine IP-10 release, further
demonstrated that the LPSBv-induced IL-10 release is not
regulated by IFN type I dependent pathways.
Therefore, the findings in MoDCs consolidated those
achieved in MoMs and highlighted the peculiar ability of the
LPSBv to stimulate selectively the release of IL-6 and the anti-
inflammatory cytokine IL-10. It is noteworthy that the LPSBv
stimulates the production of a low amount of TNF-α
compared to IL-10 release, in contrast to what is observed
with E. coli LPS which induced a high yield of TNF-α. This
result defined a peculiar immunological property of LPSBv
which is able to promote an anti-inflammatory response rather
than the inflammation.
■ ACTIVATION OF BONE MARROW
MONOCYTE-DERIVED MACROPHAGES BY B.
VULGATUS LPS AND LIPID A
We then continued to analyze whether LPSBv and lipid ABv
showed the same ability to induce the above profile of cytokine
yield also in murine bone marrow monocyte-derived macro-
phages (BMDMs), which is the common model to analyze the
immunopotential of LPS. The release of TNF-α, IL-6, IP-10,
and IL-10 (Figure S9a−d) was quantified after 12 h of
stimulation by ELISA. In contrast to human cells, in BMDMs
stimulated with LPSBv at all concentrations the TNF-α
production (Figure S9a) was scant and significantly lower (p
< 0.001, for LPSBv vs E. coli LPS at all concentrations) than
that induced by E. coli LPS at all concentrations tested.
Likewise, IL-6 (Figure S9b), IP-10 (Figure S9c), and IL-10
(Figure S9d) values were undetectable or scantly detectable (p
< 0.05 for IL-10: LPSBv at 100 ng/mL vs untreated cells).
Conclusively, human but not murine cells seemed to be
particularly sensitive to the immunopotential of LPSBv.
■ ACTIVATION BY LPSBV AND LIPID ABV IN HEK293
CELL MODELS
To acquire major insights on the biological properties of LPSBv
and lipid ABv we tested them in the model of HEK293 cell line
stably transfected with the human CD14/MD-2/TLR4
complex. As above, LPSBv and lipid ABv, E. coli LPS, and the
lipid IVA were analyzed at the concentration of 1, 10, and 100
ng/mL. After 6 h, the activation of the nuclear factor-κB (NF-
κB) (Figure 5a) and the production of chemokine (C-X-C
Figure 3. Complete structure of the LPS from B. vulgatus mpk. The
lipid A is heterogeneous, being composed of a mixture of penta- and
tetra-acylated mono-phosphorylated species. The dotted lines indicate
the nonstoichiometric substitution. The O-chain repeating unit is
indicated in square brackets.
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motif) ligand 8 (CXCL-8 or IL-8) were measured (Figure
S8b) as the most common read-outs used to evaluate the
HEK293 cell activation upon LPS stimulation. As shown in
Figure 5a, in HEK293 hTLR4 the level of NF-κB activation
induced by LPSBv (100 ng/mL) roughly reached 7% compared
to that of E. coli LPS at the same concentration while the cells
were not responsive to lipid ABv. No CXCL-8 release was
detected upon LPSBv and lipid ABv exposure (Figure 5b). At 10
and 100 ng/mL E. coli LPS stimulated high levels of NF-κB
activation and CXCL-8 production, and no response was seen
upon stimulation with lipid IVA, in accordance with the
acylation degree.
These results did not clarify the immunopotential of LPSBv
and its lipid A detected in MoMs and MoDCs. It can be
argued that, in contrast to HEK293 hTLR4, which are cells
that do not express the TLRs,31 macrophages and dendritic
cells show the full panel of TLRs. Therefore, another TLR like
TLR2 could cooperatively work with the TLR4. In this
context, the issue of TLR2 activation by LPS is very
controversial.32 However, very recently it has been reported
that Helicobacter pylori LPS is able to activate TLR2,33
underlining that some atypical LPS could show a TLR2-
activating capacity. Therefore, we tried to understand whether
LPSBv or lipid ABv could induce a TLR2 response. The
HEK293 expressing hTLR2 were used to assess the
immunologic impact of LPSBv and lipid ABv at the
concentration of 1, 10, and 100 ng/mL as above. E. coli LPS
and lipid IVA were used in parallel. Pam3CSK4 (Pam3 CSK4)
(500 ng/mL), a synthetic triacylated lipopeptide (LP), which
mimics the acylated amino terminus of bacterial LP,
represented the positive control for a TLR2 ligand. As
expected, no activation of NF-κB (Figure 5c) and no CXCL-
8 (Figure 5d) release were detected upon stimulation with E.
coli LPS and lipid IVA. LPSBv (100 ng/mL), but not lipid ABv,
elicited a visible degree of NF-κB activation (p < 0.001 vs
untreated cells). With LPSBv CXCL-8 production was
consistent with NF-κB results (p < 0.05 for LPSBv vs E. coli
LPS, both at 100 ng/mL), and lipid ABv triggered only a scant
yield. As expected, Pam3 determined high NF-κB activation
and CXCL-8 production. These results matched with our
previous observation of a slight activation of TLR2 in murine
TLR2-HEK cells in response to LPSBv stimulation.
17
Then, HEK293 hTLR4 cells were transfected with hTLR2
and analyzed under the same conditions as above (Figure 5e,f)
to evaluate the mutual influence of both TLRs (TLR4 plus
TLR2) upon stimulation with LPSBv and lipid ABv. In contrast
to the results in HEK293 hTLR4, activation of NF-κB and
CXCL-8 release induced a certain degree of activation
Figure 4. Cytokine and chemokine release induced by LPSBv and lipid ABv in MoMs and MoDCs. Release of TNF-α (a, e), IL-6 (b, f), IP-10 (c, g),
and IL-10 (d, h) in cell free supernatants of MoMs and MoDCs, respectively. Untreated cells are the negative control in these experiments. *p <
0.05, **p < 0.01, ***p < 0.001.
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following stimulation with LPSBv (100 ng/mL) although they
were significantly lower (p < 0.001 and p < 0.01 for NF-κB and
CXCL-8, respectively: LPSBv vs E. coli LPS, both at 100 ng/
mL) than those of E. coli LPS at the same concentration. As
controls, HEK293 null cells or carrying pcDNA3, stimulated as
HEK293 hTLR2 and HEK293 hTLR4 hTLR2 cells, did not
trigger any NF-κB activation and CXCL-8 production (Figure
S10).
Importantly, LPS preparations containing highly immunoac-
tive contaminants, i.e., lipoproteins and phospholipids, that
could be responsible for the observed TLR2-mediated
signaling, have been previously reported.34 Therefore, despite
the extensive steps of purifications and the results of both the
SDS-PAGE and the Micro BCA protein assay, we performed a
further step of “repurification” of the LPSBv to eliminate
possible lipoproteins present as previously described,35,36
preceded by several washes with a mixture of chloroform−
methanol (1:2, v/v) and chloroform−methanol−water
(3:2:0.25, v/v) to remove traces of phospholipids possibly
present. No detectable proteins were observed in the repurified
LPS (LPSBv-RP) analyzed by Micro BCA protein assay (Figure
S1c), which was then employed for immunological studies on
Figure 5. Analysis of the immunopotential of LPSBv, LPSBv-RP, and lipid ABv. HEK293 cells expressing hTLR4/MD2-CD14 (a, b) or hTLR2 (c, d)
or hTLR4/MD2-CD14 and hTLR2 (e, f) were treated with LPSBv, LPSBv-RP, or lipid ABv, with E. coli LPS, with lipid IVA at the concentration of 1,
10, and 100 ng/mL, or with TLR2 agonist Pam3 CSK4 (500 ng/mL) (c−f). Untreated cells were the negative control in these experiments. Fold of
NF-κB activation in HEK293 hTLR4/MD2-CD14 (a), HEK293 hTLR2 (c), and HEK293 hTLR4/MD2-CD14 hTLR2 (e). Release of CXCL-8
release supernatants of HEK293 hTLR4/MD2-CD14 (b), HEK293 hTLR2 (d), and HEK293 hTLR2 hTLR4 cells (f). *p < 0.05, **p < 0.01, ***p
< 0.001.
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HEK293 cell lines. As shown in Figure 5, immunological tests
executed on HEK293 hTLR4, HEK293 hTLR2, and HEK293
hTLR4 hTLR2 showed a similar behavior between the LPSBv
and the repurified LPS (LPSBv-RP), thus further confirming
that the LPSBv actually activates the TLR2-mediated signaling.
■ COMPETITION TESTS OF LPSBV AND LIPID ABV
WITH AGONISTIC LPS IN HEK293 CELL MODEL
Some underacylated lipid A and/or unusual LPS, containing,
for example, long fatty acid chains, do show an inhibitory
activity against endotoxically active LPS in human cells.37−40 In
line with this issue, we tested the ability of LPSBv or Lipid ABv
to compete with the hexa-acylated, fully immunocompetent E.
coli LPS to engage the hTLR4 mediated signaling. With this
aim, HEK 293 hTLR4 cells were preincubated for 1 h with
LPSBv or lipid ABv and stimulated with 10 and 100 ng/mL of E.
coli LPS for 4 h (Figure S11a−d). NF-κB activation and
CXCL-8 production were quantified after this time. Lipid IVA
was used in parallel under the same conditions as for LPSBv and
lipid ABv as a control of the inhibitory effect. Under these
experimental conditions, LPSBv and lipid ABv did not
significantly inhibit the activity of NF-κB upon E. coli LPS
stimulation at all the concentrations tested, albeit the trend of
NF-κB was reduced with respect to the only stimulation with
E. coli LPS (Figure S11a,b). This kinetics was confirmed and
strengthened with the CXCL-8 yield as lipid ABv (1 and 10 ng/
mL) plus E. coli LPS (10 ng/mL) reduced significantly the
production of CXCL-8 of E. coli LPS (10 ng/mL) alone (p <
0.01) (Figure S11c). Likewise, LPSBv and Lipid ABv (1 and 10
ng/mL) plus E. coli LPS (100 ng/mL) induced a lower release
of CXCL-8 than E. coli LPS (100 ng/mL) alone (p < 0.01)
(Figure S11d). As expected, lipid IVA showed an inhibitory
activity on E. coli LPS for NF-κB and CXCL-8 production at all
the concentrations tested (p < 0.001). Therefore, LPSBv and
lipid ABv show a weak inhibitory activity toward E. coli LPS.
These data are in agreement with the observation that LPSBv is
only a slight competitive inhibitor of E. coli LPS for binding to
murine TLR4.17
■ DISCUSSION
The involvement of the LPS in the host-gut microbiota cross-
talk is receiving a growing interest as it is shown to play a
crucial role, depending on its fine structure, triggering or
preventing inflammation by modulating the host immune
responses. Different LPS structures are at the basis of such
divergent activities, with gut commensal LPS exerting only
weak immune inflammatory reactions. Within this frame, the
structural characterization of LPS from gut microbiota will
potentially provide peculiar chemical characteristics which will
be surely related to interesting immunological properties.
In this study, we fully established the LPS structure isolated
from B. vulgatus mpk, a member of the genus Bacteroides which
is predominant in mouse and human microbiota and whose
health-promoting effects in murine model systems were
previously described.17 Briefly, the lipid A resulted in a
heterogeneous mixture of tetra- and penta-acylated species
(Figure 3 and Figure S4) whose nature and distribution of the
fatty acids were as previously reported.26 This lipid A blend
resulted in being essentially phosphorylated only at the
reducing glucosamine unit, and no lipid A species with a
higher acylation and/or phosphorylation degree have been
detected. As for the saccharide portion, the core region was
built up of a hexa-saccharide bearing a phosphorylated Kdo
unit, in turn, substituted at position O-5 by a Rhap residue.
This latter was found to be a branched monosaccharide
bearing a β-Galf unit at its position O-3 and, at position O-4, a
β-Galp unit. The latter was, in turn, disubstituted by α-Fucp
and, finally, by a β-Glcp which was established to be the
residue substituted by the first rhamnose of the O-chain. The
O-chain structure was built up of repeating units of β-Manp
and α-Rhap, in agreement with what was previously
published26 where we have further established the biological
O-chain repeating unit which starts with α-Rhap. Notably, to
the best of our knowledge, this is the first time that the full
structure of an LPS from Bacteroides spp. is completely defined
since so far only relatively little information and disjointed and
partial structures are available concerning Bacteroides LPS
saccharide domains.9
The investigation of the immunological properties of LPSBv
in human macrophages showed a weaker capability to elicit
proinflammatory cytokine production than E. coli LPS.
Therefore, similar to what was observed in murine in vitro
systems, it is tempting to translate in human immune cells the
hypothesis of LPSBv as acting providing a basic anti-
inflammatory intracellular transcription program, without
exceeding a proinflammatory threshold, that could exert a
“protective” role for the colonized host. In addition, our results
showed that LPSBv was able to highly stimulate the release of
IL-10, a potent anti-inflammatory cytokine that restrains
pathogenic inflammation in the gut. Nevertheless, LPSBv
promoted some production of the pleiotropic cytokine IL-6
whereas the proinflammatory cytokine TNF-α was only scantly
stimulated. It might be speculated that LPSBv plays a key role in
the host immune responses by balancing the excessive
inflammation potentially induced by IL-6 with the anti-
inflammatory activity of IL-10. The resulting immune balance
is crucial to drive optimal immune responses without causing
an overexuberant inflammation at the level of intestinal mucosa
where microbiota proliferate.41
The use of HEK cell lines transfected with TLR4 confirmed
a weaker agonistic effect of LPSBv compared to LPS from E.
coli. In addition, HEK TLR2 cell lines showed a specific and
significant interaction only with LPSBv. Interestingly, this
interaction was upregulated by the coexpression of TLR4 and
TLR2 on the HEK cell lines, showing a clear synergistic effect
between the two TLRs in NF-κB activation and CXCL-8
production.
It is intriguing to speculate that the overall LPSBv particular
architecture might have a role in the MD-2/TLR4 complex-
ation with the LPS itself and the following downstream
signaling. Within this frame, it has been recently demonstrated
that total LPS from fecal samples of healthy adult humans,
mainly composed of Bacteroidetes species, has the capability to
facilitate host tolerance of gut microbes by potently
antagonizing the host TLR4 pathway.42 Indeed, it is widely
known that the immunogenicity, or the strength of the
intracellular signaling, triggered by LPS via TLR4 is mostly
mediated by the lipid A structure.43 Indeed, a reduction in the
number of the lipid A acyl moieties typically correlates with a
decreased immunopotency of the LPS. Contextually, hypo-
acylated lipid A forms are conserved across Bacteroidetes
species,44 as also confirmed by our data which are in agreement
with previous reported information regarding the tendency of
Bacteroides species to accumulate linear or branched fatty acids
with 15−17 carbon atoms in their LPS lipid A moiety.42,44,45
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Furthermore, both 1- and 4′- phosphates on the lipid A
disaccharide backbone were demonstrated to be important
moieties for MD-2/TLR4 receptor complex activation.4 Since
LPSBv possesses only one phosphate at position 1 of the
reducing glucosamine, this may also contribute to its weaker
(compared to E. coli LPS) agonistic effects as a missing 4′-
phosphate was demonstrated to result in a 100-fold reduction
in endotoxic activity.46 Moreover, it has been recently
demonstrated that the enzyme LpxF, which is responsible for
removing a single phosphate from the lipid A, is conserved
across commensal Bacteroidetes and serves to enhance
bacterial resistance to antimicrobial peptides, thus favoring
bacterial resilience in the intestine.47 Finally, recent studies
revealed that not only do the the lipid A phosphorylation and
acylation pattern determine LPS toxicity, but also the
occurrence of either positive or negative charged groups,
other than glucosamine backbone associated phosphates, can
increase LPS immunopotency.48 In this case, besides Kdo and
reducing glucosamine-phosphate, LPSBv contains no further
charged groups either in the lipid A part or in the core OS.
Nevertheless, with this study we highlight the involvement
also of TLR2 in the immunopotential of LPSBv. This is a
fascinating aspect since it has been demonstrated that the
TLR2 pathway establishes colonization for commensals of the
human gut microbiota.49 In this frame, although it has been
demonstrated that some atypical LPSs are able to activate the
TLR2 signaling pathway,33 it is still unclear how TLR2
recognizes LPS. Given the controversial data about the
presence of TLR2-stimulating contaminants in LPS prepara-
tions of Bacteroides spp., here we proved that the isolated LPSBv
(as well as LPSBv-RP) was devoid of any immunoactive
contaminant, thus further confirming the ability of this LPS to
activate the TLR2 signaling in human cells, as also previously
observed for murine TLR2-HEK cells in response to LPSBv
stimulation.17 How to relate this crucial point to the structure
of LPSBv will be a logical follow up of the present results.
Within this context, under the structural point of view, the
presence, in the inner part of the LPS core, of Galf, which is
known to be immunogenic to mammals, is surely an innovative
signature for bacterial LPS. Indeed, the occurrence of five
membered sugar rings in the LPS core OS is very rare, and to
the best of our knowledge, it has only been found in an
environmental Shewanella50 strain as well as in the
thermophilic bacterium Thermomonas hydrothermalis.51 It is
worth noting that particular bacterial hallmark monosacchar-
ides, such as Galf, that can be recognized by lectins of the
eukaryotic innate immunity system whose role is yet to be
identified, have been recently reported.52−54 Indeed, we firmly
believe that the combination of all the peculiar chemical
features of the LPSBv molecule influences its net effect on
human immune cells, and on this ground, the role of the Galf
unit in LPSBv immunological properties is intriguing and
requires a future in-depth study at the molecular level. In
support of our hypothesis, a recent work by Erturk-Hasdemir
et al. (2019)12 demonstrated that a covalently linked lipid
anchor in polysaccharide A, the zwitterionic capsular
polysaccharide of B. f ragilis, was critical for the initiation of
the anti-inflammatory immune response through the simulta-
neous activation of the TLR2 signaling (by the lipid anchor)
and the Dectin-1 pathway (by the polysaccharide moiety).
Similarly, we deem that the saccharide regions of LPSBv heavily
contribute and collaborate with the lipid A portion in dictating
the innate immune signaling mechanisms leading to the
activation of an anti-inflammatory response.
By this study we intended to provide the complete structure
of a commensal bacterium LPS and start the search for
molecular motifs that might be important for LPS−eukaryotic
cell interactions at the gut level. We are not aware of whether
this new structure is a “chemical paradigm” of the intestinal
microbiota LPS since, so far, only very few chemical structures
of intestinal commensals have been established.9,55 Certainly,
we can say that a thin border exists between the homeostatic
balance maintained by commensal gut microbes and the war
unleashed by bacterial pathogens invading gut mucosa. This
thin line is, at least in part, chemically represented by the LPS
structure which, in the case of commensals, responds to
particular chemical requirements, such as peculiar fatty acids
chemistry, location, and distribution and peculiar mono-
saccharide presence in the core region (i.e., Galf). In this
specific case, this chemical structure also has a different
immunological behavior, i.e., the mild activating effect and the
combined TLR2/TLR4 activation.
■ EXPERIMENTAL SECTION
Extraction, Purification, and “Repurification” of LPS
from B. vulgatus mpk. Bacterial dried cells (5 g) were
extracted through the hot phenol/water procedure.18 The row
LPS (300 mg) was checked by SDS-PAGE after gel silver
staining19 revealing a smooth-type LPS only in the water
phase. In order to remove cell contaminants, an intensive
enzymatic treatment by RNase (Roth), DNase (Roth), and
Proteinase K (Roth) at 37 and 56 °C was executed, followed
by exhaustive dialysis. In order to further purify the LPS
material, several ultracentrifugation steps (4 °C, 100 000g, 24
h) and a gel-filtration chromatography were also performed.
The SDS-PAGE followed by silver staining was repeated to
check the degree of purity of the isolated LPS confirming the
previous analysis. Furthermore, an additional SDS-PAGE
followed by Coomassie Brilliant Blue (Sigma-Aldrich) gel
staining to evaluate the presence of protein/lipoprotein
contaminants was also executed. In both SDS-PAGE analyses,
the purified LPSBv was prepared at the desired concentration
(1 mg/mL) and boiled for 10 min, and then, 0.5, 1, 2, 4, and 8
μL/well were loaded on a 13.5% SDS gel with a 5% stacking
gel and separated using a mini-PROTEAN electrophoresis
instrument (Bio-Rad Laboratories). Silver and Coomassie
Brilliant Blue staining of the gels was executed according to the
standard protocols.
In order to establish the protein content of the purified
LPSBv, the Pierce Micro BCA protein assay (Thermo
Scientific) has been performed following the manufacturer
protocol, at an LPS concentration 100 times higher than the
concentration used in the cellular experiments. Finally, the
assay was repeated in the presence of 2% SDS as suggested by
the manufacturer to remove the significant lipid interfer-
ence.20,21
In order to further exclude the presence of any TLR2-
stimulating contaminant in the LPSBv preparation, an aliquot of
LPSBv, previously treated to remove nucleic acids and proteins,
dialyzed, ultracentrifuged, and chromatographed as described
above, underwent several washes with a mixture of chloro-
form−methanol (1:2, v/v) and chloroform−methanol−water
(3:2:0.25, v/v) currently employed to remove phospholipids.
Once the organic solvents were removed completely, the
sample was subjected to the “repurification” protocol by
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Hirschfeld et al.36 to remove any traces of lipoproteins possibly
contaminating the isolated LPSBv. The so-obtained LPS
(LPSBv-RP) was analyzed through the Pierce Micro BCA
protein assay (Thermo Scientific). Finally, LPSBv-RP and LPSBv
were both employed for the immunological tests. No
unexpected or unusually high safety hazards were encountered
in this work.
Chemical Analyses of LPS from B. vulgatus mpk.
LPSBv monosaccharide content was established by analysis of
the acetylated O-methyl glycoside derivatives obtained by
treatment with HCl/MeOH (1.25 M, 85 °C, 24 h) followed by
an acetylation step with acetic anhydride in pyridine (85 °C,
30 min). The absolute configuration of each sugar unit was
defined through the evaluation of the O-octylglycoside
derivatives as previously described.22 The sugar linkage pattern
was determined by the Ciucanu method:23,24 briefly, an aliquot
of sample was suspended in DMSO to which NaOH in powder
was added and then methylated with CH3I, hydrolyzed with
trifluoroacetic acid (4 M, 100 °C, 4 h), carbonyl reduced with
NaBD4, and acetylated with pyridine and acetic anhydride. The
total fatty acid content was established on intact LPS by
treating with HCl (4 M, 100 °C, 4 h) followed by NaOH (5
M, 100 °C, 30 min). The pH was adjusted to reach slight
acidity. After extraction in chloroform, fatty acids were then
methylated with diazomethane.25 All chemical analyses were
performed by means of a gas−liquid chromatography (GLC-
MS) Agilent Technologies 6850A instrument equipped with a
mass selective detector 5973N and a Zebron ZB-5 capillary
column (Phenomenex, 30 m × 0.25 mm i.d., flow rate 1 mL/
min, He used as carrier gas) and using the following
temperature program: 140 °C/240 °C at 3 °C/min.
Isolation of the LPSBv Saccharide Domain. An aliquot
of pure LPS was treated with anhydrous hydrazine (2 mL),
stirred at 37 °C for 90 min, cooled, poured into ice-cold
acetone (20 mL), and allowed to precipitate. The precipitate
was centrifuged (4000g, 30 min), washed with ice-cold
acetone, dried, dissolved in water, and lyophilized. The O-
deacylated product was then N-deacylated with 4 M KOH.
The removal of salts was executed by gel-filtration chromatog-
raphy on a Sephadex G-10 column (Pharmacia, 50 × 1.5 cm).
The fully deacylated product was further purified on a
Toyopearl TSK HW-50 instrument (Tosoh Bioscience).
NMR Spectroscopy. 1D and 2D 1H NMR spectra were
recorded on a Bruker 600 DRX instrument equipped with a
cryoprobe. The solvent employed was D2O, and the temper-
ature was 298 K and pD 7. Spectra calibration was performed
with internal acetone (δH 2.225 ppm, δC 31.45 ppm).
31P
NMR experiments were carried out with a Bruker DRX-400
spectrometer; aqueous 85% phosphoric acid was used as the
external reference (δ = 0.00 ppm). The double-quantum
filtered phase sensitive correlation spectroscopy (DQF-COSY)
experiment was carried out by using data sets of 4096 × 256
points. Total correlation spectroscopy (TOCSY) experiments
were executed with spinlock times of 100 ms, using data sets
(t1 × t2) of 4096 × 256 points. Rotating frame Overhauser
enhancement spectroscopy (ROESY) and nuclear Overhauser
enhancement spectroscopy (NOESY) experiments were
recorded by using data sets (t1 × t2) of 4096 × 256 points
and by using mixing times between 100 and 400 ms. In all
homonuclear experiments the data matrix was zero-filled in
both dimensions to give a matrix of 4 K × 2 K points and was
resolution enhanced in both dimensions by a cosine-bell
function before Fourier transformation. The determination of
coupling constants was obtained by 2D phase sensitive DQF-
COSY.56,57 Heteronuclear single quantum coherence (1H, 13C
HSQC) and heteronuclear multiple bound correlation (1H,
13C HMBC) experiments were recorded in 1H-detection mode
by single-quantum coherence with proton decoupling in the
13C domain using data sets of 2048 × 256 points. 1H, 13C
HSQC was executed using sensitivity improvement and in the
phase-sensitive mode using Echo/Antiecho gradient selection,
with multiplicity editing during the selection step.58 The 1H,
13C HMBC experiment was optimized on long-range coupling
constants with the low-pass J filter to suppress one-bound
connectivity, using gradient pulses for selection. A delay of 60
ms was employed for the evolution of long-range correlations.
A long-range coupling constant value of 6 Hz was used. The
data matrix in both heteronuclear experiments was extended to
2048 × 1024 points using forward linear prediction.59
Molecular Modeling. Computational studies and MD
simulations of the following molecules were performed: LPSBv
lipid A molecules (TetraLipA and PentaLipA) and tetra- and
penta-acylated LPSBv (LPSBv-tetra and LPSBv-penta). The
modeled 3D structures were in agreement with the NMR
data as can be deduced from the monitoring of selected inter-
residue distances (not shown).
Building of the Ligands. Compounds TetraLipA,
PentaLipA, LPSBv-tetra, and LPSBv-penta were constructed
using the Maestro interface.60 The 3D coordinates of E. coli
LPS from PDB ID 3FXI were used as a template. The resulting
structures were minimized using the OPLS3 force field, water
as a solvent, and steepest descent as the method of
minimization, with a maximum of 10 000 iterations.
Parameter Derivation. Parameterization of new units was
performed using Gaussian0961 by optimizing the geometries
with the 6-31G basis set at the Hartree−Fock level of theory.
Charges were derived by applying the RESP methodology
implemented in Antechamber, assigning the general Amber14
force field (GAFF) atom types.
Molecular Dynamics (MD) Simulations. All the MD
simulations were carried out using Amber14.62 Each
compound was solvated with water molecules (TIP3 force
field), and Na+ counterions were added. Several steps of
equilibration were performed before running the MD
simulation. The first one consisted of 1000 steps of steepest
descent minimization followed by 7000 steps of conjugate
gradient minimization; a 100 kcal/(mol A2) harmonic
potential constraint was applied to the solute. In the four
subsequent steps, the harmonic potential was progressively
lowered, respectively, to 10, 5, and 2.5 kcal/(mol A2)) for 600
steps of conjugate gradient minimization each time, and then,
the whole system was minimized uniformly. In the following
step, the system was heated from 0 to 100 K using the
Langevin thermostat in the canonical ensemble (NVT) while
applying a 20 kcal/(mol A2) harmonic potential restraint on
the proteins and the ligand. The next step heated up the
system from 100 to 300 K in the isothermal−isobaric ensemble
(NPT) under the same restraint condition as in the previous
step. In the last step, the same parameters were used to
simulate the system for 100 ps, but no harmonic restraint was
applied. At this point, the system was ready for the production
run, which was performed using the Langevin thermostat
under NPT ensemble, at a 2 fs time step. A 100 ns trajectory
was generated and further analyzed.
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ESI MS and MS/MS Analysis. MS spectra of the
saccharide part of LPSBv were acquired on an amazon SL ion
trap (IT) mass spectrometer with electrospray ionization (ESI)
(Bruker Daltonics). The sample (75 μg) was dissolved in 50
μL of acetonitrile/water/formic acid solution (100:100:1, v/v/
v) and analyzed in negative ion mode. The ion corresponding
to core OS (m/z 667.3) was analyzed by MS/MS. Source
parameters were as follows: sample flow, 3 μL/min; ion source
temperature, 200 °C; nitrogen flow, 5 L/min at a pressure of 8
psi. Spectra were scanned in the 200−2000 m/z range. He was
used as the collision gas in the IT. The system was calibrated
using ESI-L tuning mix (Agilent Technologies).
Isolation of the Lipid A Fraction from LPSBv. Isolation
of lipid A was achieved by mild acid hydrolysis by using acetate
buffer (1 mL, pH = 4.4) promoted by SDS (1 mg/mL) on ca.
20 mg of isolated LPS at 100 °C. The solution was extracted
three times with CHCl3/MeOH/H20 (100:30:30, v/v/v) and
centrifuged (4 °C, 7000g, 15 min). The organic phase
containing the lipid A was further purified by several washes
with distilled water and then freeze-dried.
MALDI MS Analysis on Isolated A from LPSBv. Lipid A
isolated after mild acid hydrolysis of LPSBv was analyzed with a
MALDI-TOF ultrafleXtreme spectrometer (Bruker Daltonics).
100 μg of lipid A was dissolved in 100 μL of milli-Q water after
10 min of incubation at 40 °C in the ultrasonic bath. 9H-
pyrido(3,4)-indole (10 mg) was mixed with 1 mL of CHCl3/
MeOH (1:1, v/v), and 0.5 μL of the matrix was spotted onto
the matrix. The sample was analyzed in reflectron, negative ion
mode, scan range: m/z 700−3500. Instrument was calibrated
within 1000−3150 Da mass range, using peptide mixture
(Peptide Calibration Standard, Bruker Daltonics).
HEK 293 Cell Culture, Transfection, and Stimulation.
The HEK293 cell line, stably transfected with human TLR4/
MD2-CD14 (InvivoGen), was seeded into a 24-well plate at
the concentration of 5 × 105 cells/mL. 48 h after seeding, the
cells were transiently transfected through PolyFect transfection
reagent (Qiagen) with a reaction mix containing 250 ng of
Firefly luciferase reporter constructs, pGL3.ELAM.tk [harbor-
ing nuclear factor kappa B (NF-κB) promoter sequences], and
25 ng of Renilla luciferase reporter plasmid, pRLTK (as an
internal control). For hTLR2, HEK293 cells or HEK293 cells
hTLR4/MD2-CD14 were transfected through PolyFect trans-
fection reagent with the plasmid pcDNA3-TLR2-YFP
(pcDNA3-TLR2-YFP was a gift of Doug Bolenbock, Addgene
plasmid 13016) and treated as above. The day after, the cells
(HEK293 hTLR4/MD2-CD14, HEK293 hTLR2, or HEK293
hTLR4/MD2-CD14 hTLR2) were incubated with different
concentrations of LPSBv, LPSBv-RP, or lipid ABv (1, 10, and 100
ng/mL) or with purified E. coli LPS (LPS-EB ultrapure;
InvivoGen) or with synthetic lipid IVA used at the same
concentrations as above, for 6 h to analyze NF-κB activity
(dual luciferase reporter assay system, Promega) and to
measure CXCL-8 release (DuoSet R&D system). In the
experiments including the TLR2 in addition to LPSBv, LPSBv-
RP, and lipid ABv, Pam3 CSK4 (Pam3 CSK4) (InvivoGen)
(500 ng/mL) was used as a positive control. Where necessary,
HEK293 cells only or HEK293 cells pcDNA3 were exposed to
LPSs and lipid A or Pam3 CSK4, as above. For the
competition assay, HEK 293 hTLR4/MD2-CD14 cells were
primed with 1, 10, and 100 ng/mL of LPSBv or lipid ABv, or
lipid IVA for 1 h and then exposed to E. coli LPS (10 and 100
ng/mL) for 4 h. After this time, NF-κB activity and CXCL-8
production were measured.
Human Macrophage and Dendritic Cell Isolation,
Cultures, and Stimulation. Peripheral blood mononuclear
cells (PBMCs) were isolated from buffy coats obtained by the
blood bank of Sapienza University or Sanquin Blood bank,
Amsterdam, The Netherlands, from healthy adult volunteers
(blood donors) following written informed consent in
accordance with the Declaration of Helsinki. Each experiment
included two buffy coats from two healthy adult volunteers and
was carried out in triplicate.
For macrophages, PBMCs were obtained through a density
gradient. CD14+ monocytes were isolated using the MACS
microbead system (Miltenyi Biotec, Bergisch Gladbach,
Germany). The monocytes were cultured for 6 days in
RPMI 1640 (Lonza) supplemented with 10% heat-inactivated
FBS (Euroclone Fetal Bovine Serum, GE Healthcare Life
Sciences), 100 μM nonessential amino acids, 1 mM sodium
pyruvate, 1000 U/mL penicillin, and 1000 U/mL streptomycin
(all from Lonza) and 60 ng/mL GM-CSF (granulocyte-
macrophage colony-stimulating factor) (Miltenyi Biotec) to
obtain human macrophages (MoMs).
For dendritic cells, CD14+ monocytes were isolated using
the MACS microbead system (Miltenyi Biotec, Bergisch
Gladbach, Germany). The monocytes were cultured for 5
days in RPMI 1640 (Lonza) supplemented with 10% heat-
inactivated FBS (HyClone Fetal Bovine Serum, GE Healthcare
Life Sciences), 100 μM nonessential amino acids, 1000 U/mL
penicillin, and 1000 U/mL streptomycin (all from Lonza), 20
ng/mL IL-4, and 50 ng/mL GM-CSF (both Miltenyi Biotec)
to obtain immature human dendritic cells. MoDCs were
characterized by immunostaining with CD11c, CD14, and
CD80 (all from BD Pharmingen) through a flow cytometric
analysis.
For MoMs and MoDCs stimulation, the cells were seeded in
cell plates (2.5 × 105 cells/well for MoMs and 5 × 105 cells/
well for MoDCs) and exposed to 1, 10, and 100 ng/mL of
LPSBv or lipid ABv, or lipid IVA or E. coli LPS used at the same
concentrations for 12 h. Cell supernatants were then collected
and processed for ELISA to measure the levels of TNF-α, IL-
10, IL-6, and IP-10.
As for the time-course of IL-6 and IL-10 release by MoDCs,
cells were stimulated with LPSBv (10 ng/mL) after 1, 2, 4, 6, 8,
and 24 h, and with 100 ng/mL after 1 and 24 h. Data are
expressed as percentage of effect, and they are normalized over
the MoDCs treated with LPS from E. coli (10 ng/mL at 24 h)
set at 100%.
Bone Marrow-Monocyte-Derived Macrophage
(BMDM) Isolation, Culture, and Stimulation. C57BL/6
mice were purchased from Charles River. BMDMs were
derived from the bone marrow cells collected from 5 week old
female mice, as already reported.39 Animal studies were
conducted according to protocols approved by the University
of Rome La Sapienza and adhered strictly to the Italian
Ministry of Health guidelines for the use and care of
experimental animals. BMDMs were differentiated during 7
days in RPMI 1640 (Lonza), supplemented with 10% of heat-
inactivated FBS (HycloneTM, Euroclone), 1% of L-glutamine
(Lonza), 1% sodium pyruvate (Lonza), 1% NEAA (Lonza),
0.5% 2-ME (Gibco), and 40 ng/mL macrophage colony-
stimulating factor (M-CSF; Miltenyi Biotec). BMDMs were
seeded into 24-well plate (5 × 105 cells per well) and were
incubated with different concentrations of LPSBv or lipid ABv
(1, 10, and 100 ng/mL), E. coli LPS, or with lipid IVA at the
same concentrations for 12 h. After this, cell supernatants were
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then collected and processed for ELISA to measure the levels
of TNF-α and IL-10, IL-6, and IP-10.
ELISA Assay. Cytokine and chemokine concentrations
were determined by commercially available ELISA kits (Duo
Set Kit R&D systems or ThermoFisher Scientific IFN alpha
Human ELISA Kit). The absorbance was measured on a LT-
4000 microplate reader (Labtech) (Hercules, CA).
Statistical Analysis. Data were presented as mean ± SD of
at least 4 independent experiments (for human macrophages
and dendritic cells, two donors for each experiment carried out
in triplicate, as stated above). The statistical analysis has been
carried out through GraphPad Prism software. For multiple
group comparison the software used the multiple t test
followed by Sidak−Bonferroni correction. Statistical signifi-
cance was set at *p ≤ 0.05.
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Ernst, R. R.; Wüthrich, K. Improved spectral resolution in COSY (1)
H NMR spectra of proteins via double quantum filtering. Biochem.
Biophys. Res. Commun. 1983, 117, 479.
(58) States, D. J.; Haberkorn, R. A.; Ruben, D. J. A two-dimensional
nuclear Overhauser experiment with pure absorption phase in four
quadrants. J. Magn. Reson. 1982, 48, 286−292.
(59) Stern, A. S.; Li, K. B.; Hoch, J. C. Modern spectrum analysis in
multidimensional NMR spectroscopy: comparison of linear-predic-
tion extrapolation and maximum-entropy reconstruction. J. Am. Chem.
Soc. 2002, 124, 1982−1993.
(60) Schrödinger Release 2019−1; Maestro: New York, NY, 2019.
(61) Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria, G. E.;
Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Petersson,
G. A.; Nakatsuji, H.; Li, X.; Caricato, M.; Marenich, A. V.; Bloino, J.;
Janesko, B. G.; Gomperts, R.; Mennucci, B.; Hratchian, H. P.; Ortiz, J.
V.; Izmaylov, A. F.; Sonnenberg, J. L.; Williams-Young, D.; Ding, F.;
Lipparini, F.; Egidi, F.; Goings, J.; Peng, B.; Petrone, A.; Henderson,
T.; Ranasinghe, D.; Zakrzewski, V. G.; Gao, J.; Rega, N.; Zheng, G.;
Liang, W.; Hada, M.; Ehara, M.; Toyota, K.; Fukuda, R.; Hasegawa, J.;
Ishida, M.; Nakajima, T.; Honda, Y.; Kitao, O.; Nakai, H.; Vreven, T.;
Throssell, K.; Montgomery, J. A., Jr.; Peralta, J. E.; Ogliaro, F.;
Bearpark, M.; Heyd, J. J.; Brothers, E. N.; Kudin, K. N.; Staroverov, V.
N.; Kobayashi, R.; Normand, J.; Raghavachari, K.; Rendell, A.; Burant,
J. C.; Iyengar, S. S.; Tomasi, J.; Cossi, M.; Millam, J. M.; Klene, M.;
Adamo, C.; Cammi, R.; Ochterski, J. W.; Martin, R. L.; Morokuma,
K.; Farkas, O.; Foresman, J. B.; Fox, D. J. Gaussian 16, revision B.01;
Gaussian, Inc.: Wallingford CT, 2016.
(62) Case, D.; Berryman, J.; Betz, R.; Cerutti, D.; Cheatham, T., III;
Darden, T.; Duke, R.; Giese, T.; Gohlke, H.; Goetz, A. AMBER 2015;
University of California: San Francisco, 2015.
ACS Central Science http://pubs.acs.org/journal/acscii Research Article
https://dx.doi.org/10.1021/acscentsci.0c00791
ACS Cent. Sci. XXXX, XXX, XXX−XXX
O
